Compare, Analyse Natco Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-19
TEVA PHARMA
Dec-13
NATCO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8492,994-   
Low Rs5572,601-   
Sales per share (Unadj.) Rs573.81,718.5-  
Earnings per share (Unadj.) Rs176.0107.4-  
Cash flow per share (Unadj.) Rs198.2246.3-  
Dividends per share (Unadj.) Rs6.2593.98-  
Dividend yield (eoy) %0.93.4 26.5%  
Book value per share (Unadj.) Rs842.71,909.0-  
Shares outstanding (eoy) m36.50848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.21.6 75.2%   
Avg P/E ratio x4.026.1 15.3%  
P/CF ratio (eoy) x3.511.4 31.2%  
Price / Book Value ratio x0.81.5 56.9%  
Dividend payout %3.687.5 4.1%   
Avg Mkt Cap Rs m25,6602,372,585 1.1%   
No. of employees `0005.044.9 11.0%   
Total wages/salary Rs m3,5590-   
Avg. sales/employee Rs Th4,225.332,424.7 13.0%   
Avg. wages/employee Rs Th718.00-   
Avg. net profit/employee Rs Th1,295.92,025.5 64.0%   
INCOME DATA
Net Sales Rs m20,9451,457,326 1.4%  
Other income Rs m1,3020-   
Total revenues Rs m22,2471,457,326 1.5%   
Gross profit Rs m7,948399,090 2.0%  
Depreciation Rs m810117,797 0.7%   
Interest Rs m19328,624 0.7%   
Profit before tax Rs m8,247252,668 3.3%   
Minority Interest Rs m01,148 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,863 0.0%   
Tax Rs m1,823-3,085 -59.1%   
Profit after tax Rs m6,42491,038 7.1%  
Gross profit margin %37.927.4 138.6%  
Effective tax rate %22.1-1.2 -1,810.6%   
Net profit margin %30.76.2 491.0%  
BALANCE SHEET DATA
Current assets Rs m23,472984,273 2.4%   
Current liabilities Rs m7,287858,369 0.8%   
Net working cap to sales %77.38.6 894.4%  
Current ratio x3.21.1 280.9%  
Inventory Days Days9291 101.5%  
Debtors Days Days8896 92.0%  
Net fixed assets Rs m18,648475,995 3.9%   
Share capital Rs m3653,587 10.2%   
"Free" reserves Rs m34,5250-   
Net worth Rs m30,7601,618,813 1.9%   
Long term debt Rs m0745,163 0.0%   
Total assets Rs m43,0313,330,458 1.3%  
Interest coverage x43.79.8 445.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 111.2%   
Return on assets %15.43.6 428.0%  
Return on equity %20.95.6 371.4%  
Return on capital %27.44.9 556.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5970-   
CASH FLOW
From Operations Rs m6,688232,222 2.9%  
From Investments Rs m-6,122-82,286 7.4%  
From Financial Activity Rs m-509-278,566 0.2%  
Net Cashflow Rs m66-128,630 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.74 Rs / USD

Compare NATCO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NATCO PHARMA With: NOVARTIS  GSK PHARMA  FRESENIUS KABI ONCO.  JUBILANT LIFE SCIENCES  DR. REDDYS LAB  



Today's Market

Sensex Ends 181 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours but ended their session off day's high.

Related Views On News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints? (Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020 (Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks (The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Nov 20, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - DR. DATSONS LABS COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS